ZIM
LFCR icon

Zacks Investment Management’s Lifecore Biomedical LFCR Stock Holding History

Zacks Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,324
Closed -$147K – 617
2017
Q3 		$147K Buy
11,324
+100
+0.9% +$1.32K ﹤0.01% 552
2017
Q2 		$167K Buy
+11,224
New +$156K ﹤0.01% 549

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Zacks Investment Management's LFCR Position: Q4 2017 in Review

Zacks Investment Management sold out of Lifecore Biomedical (LFCR) in Q4 2017, closing a stake of 11,324 shares — an estimated $147K sold.

Zacks Investment Management first reported a position in LFCR in Q2 2017 and held it in 2 quarters. The position peaked at $167K in Q2 2017. 91 funds tracked by Wall St. Rank hold LFCR as of Q4 2017.

  • Zacks Investment Management reported no remaining Lifecore Biomedical position as of Q4 2017 after selling out during the quarter.
  • Zacks Investment Management sold 11,324 Lifecore Biomedical shares in Q4 2017, an estimated $147K.
  • Zacks Investment Management first reported a position in Lifecore Biomedical in Q2 2017 and held it in 2 quarters.
  • Zacks Investment Management's Lifecore Biomedical position peaked at $167K in Q2 2017.
  • 91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2017.

Based on Zacks Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.